Biocept Stock Forward View - Simple Exponential Smoothing

BIOCQ Stock   0.0001  0.00  0.00%   
Biocept Stock outlook is based on your current time horizon. Although Biocept's naive historical forecasting may sometimes provide an important future outlook for the firm, we suggest always cross-verifying it against solid analysis of Biocept's systematic risk associated with finding meaningful patterns of Biocept fundamentals over time.
As of today the rsi of Biocept's share price is below 20 suggesting that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 0

 Sell Peaked

 
Oversold
 
Overbought
The successful prediction of Biocept's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Biocept, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Biocept's stock price prediction:
Quarterly Revenue Growth
(0.90)
Using Biocept hype-based prediction, you can estimate the value of Biocept from the perspective of Biocept response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Exponential Smoothing forecasted value of Biocept on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0.000067 and the sum of the absolute errors of 0.

Biocept after-hype prediction price

    
  USD 9.4E-5  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Biocept to cross-verify your projections.
To learn how to invest in Biocept Stock, please use our How to Invest in Biocept guide.

Biocept Additional Predictive Modules

Most predictive techniques to examine Biocept price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Biocept using various technical indicators. When you analyze Biocept charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Biocept simple exponential smoothing forecast is a very popular model used to produce a smoothed price series. Whereas in simple Moving Average models the past observations for Biocept are weighted equally, Exponential Smoothing assigns exponentially decreasing weights as Biocept prices get older.

Biocept Simple Exponential Smoothing Price Forecast For the 11th of February 2026

Given 90 days horizon, the Simple Exponential Smoothing forecasted value of Biocept on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0.000067, mean absolute percentage error of 0.00000012, and the sum of the absolute errors of 0.
Please note that although there have been many attempts to predict Biocept Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Biocept's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Biocept Stock Forecast Pattern

Backtest Biocept  Biocept Price Prediction  Research Analysis  

Biocept Forecasted Value

In the context of forecasting Biocept's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Biocept's downside and upside margins for the forecasting period are 0.000001 and 128.47, respectively. We have considered Biocept's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
0.0001
0.000001
Downside
0.0001
Expected Value
128.47
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Simple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Biocept stock data series using in forecasting. Note that when a statistical model is used to represent Biocept stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria100.3424
BiasArithmetic mean of the errors None
MADMean absolute deviation1.0E-4
MAPEMean absolute percentage error0.3575
SAESum of the absolute errors0.004
This simple exponential smoothing model begins by setting Biocept forecast for the second period equal to the observation of the first period. In other words, recent Biocept observations are given relatively more weight in forecasting than the older observations.

Predictive Modules for Biocept

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Biocept. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Biocept's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.00009450.01
Details
Intrinsic
Valuation
LowRealHigh
0.000.000350.01
Details

Biocept After-Hype Price Density Analysis

As far as predicting the price of Biocept at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Biocept or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Biocept, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Biocept Estimiated After-Hype Price Volatility

In the context of predicting Biocept's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Biocept's historical news coverage. Biocept's after-hype downside and upside margins for the prediction period are 0.00 and 50.01, respectively. We have considered Biocept's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.0001
0.000094
After-hype Price
50.01
Upside
Biocept is out of control at this time. Analysis and calculation of next after-hype price of Biocept is based on 3 months time horizon.

Biocept Stock Price Outlook Analysis

Have you ever been surprised when a price of a Company such as Biocept is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Biocept backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Biocept, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  15.40 
128.47
 0.00  
 0.00  
0 Events / Month
0 Events / Month
In 5 to 10 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.0001
0.000094
6.10 
0.00  
Notes

Biocept Hype Timeline

Biocept is currently traded for 0.0001. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Biocept is forecasted to decline in value after the next headline, with the price expected to drop to 9.4E-5. The average volatility of media hype impact on the company price is insignificant. The price reduction on the next news is expected to be -6.1%, whereas the daily expected return is currently at 15.4%. The volatility of related hype on Biocept is about 0.0%, with the expected price after the next announcement by competition of 0.00. The company has price-to-book (P/B) ratio of 0.29. Some equities with similar Price to Book (P/B) outperform the market in the long run. Biocept recorded a loss per share of 48.17. The entity last dividend was issued on the 8th of September 2020. The firm had 1:30 split on the 17th of May 2023. Assuming the 90 days horizon the next forecasted press release will be in 5 to 10 days.
Check out Historical Fundamental Analysis of Biocept to cross-verify your projections.
To learn how to invest in Biocept Stock, please use our How to Invest in Biocept guide.

Biocept Related Hype Analysis

Having access to credible news sources related to Biocept's direct competition is more important than ever and may enhance your ability to predict Biocept's future price movements. Getting to know how Biocept's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Biocept may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
HTGMQHTG Molecular Diagnostics 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
BSPMBiostar Pharmaceuticals 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
CWWBFPlant Based Investment Corp 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
PEMTFThoughtful Brands 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
NMSCANutrition Management Services 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
VRCIVerde Science 0.00 2 per month 0.00  0.00  0.00  0.00  0.00 
CRFTFBC Craft Supply 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
MDVLQMedAvail Holdings 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
OMDDOrmand Industries 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
NBRVFNabriva Therapeutics Plc 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 

Other Forecasting Options for Biocept

For every potential investor in Biocept, whether a beginner or expert, Biocept's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Biocept Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Biocept. Basic forecasting techniques help filter out the noise by identifying Biocept's price trends.

Biocept Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biocept stock to make a market-neutral strategy. Peer analysis of Biocept could also be used in its relative valuation, which is a method of valuing Biocept by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Biocept Market Strength Events

Market strength indicators help investors to evaluate how Biocept stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Biocept shares will generate the highest return on investment. By undertsting and applying Biocept stock market strength indicators, traders can identify Biocept entry and exit signals to maximize returns.

Biocept Risk Indicators

The analysis of Biocept's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Biocept's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting biocept stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Story Coverage note for Biocept

The number of cover stories for Biocept depends on current market conditions and Biocept's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Biocept is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Biocept's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Biocept Short Properties

Biocept's future price predictability will typically decrease when Biocept's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Biocept often depends not only on the future outlook of the potential Biocept's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Biocept's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding565.1 K
Cash And Short Term Investments12.9 M

Additional Tools for Biocept Stock Analysis

When running Biocept's price analysis, check to measure Biocept's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biocept is operating at the current time. Most of Biocept's value examination focuses on studying past and present price action to predict the probability of Biocept's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biocept's price. Additionally, you may evaluate how the addition of Biocept to your portfolios can decrease your overall portfolio volatility.